---
$id: https://graph.org.ai/products/commodity/51361916
$type: Product
source: UNSPSC
code: "51361916"
title: "Methitural"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methitural

**UNSPSC Code**: 51361916
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C12H20N2O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DZQ457UJ3Y, chemically known as 4,6-(1h,5h)-pyrimidinedione, dihydro-5-(1-methylbutyl)-5-(2-(methylthio)ethyl)-2-thioxo- but generally known as methitural, which bears US NIH Compound Identifier 3032307. European Medicines Agency schedules Methitural in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08851MIG. The term METHITURAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). METHITURAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methitural under HS 29335400 and SITC kg. As of Q4 2014, METHITURAL remains the US FDA Preferred Term for this commodity. Methitural bears US NLM identifiers UMLS ID C0066138 and NCI Concept Code C83956. SMILES: S(CCC1(C(CCC)C)C(=O)NC(=S)NC1=O)C.

